Literature DB >> 21113016

Gender differences in survival following hospitalisation for COPD.

Anne V Gonzalez1, Samy Suissa, Pierre Ernst.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Gender differences in the clinical expression of COPD are increasingly recognised, but outcome differences have not been systematically examined. Gender differences in survival and rate of rehospitalisation were investigated in a large cohort of elderly patients with chronic airflow obstruction hospitalised for COPD.
METHODS: The databases from the Québec provincial health insurance plan were used. The study population included subjects aged >66 years who received ≥3 prescriptions for respiratory medications in any 1-year period between 1 January 1990 and 31 December 2001. The study cohort consisted of patients with a first hospitalisation for COPD, after selection into the study population. Patients were followed until death or 31 December 2003. The Kaplan-Meier method was used to estimate time to death and time to first hospitalisation for obstructive airways disease (COPD or asthma). The Cox proportional hazards model was used to determine the effect of male gender on all-cause mortality and rehospitalisation.
RESULTS: The cohort consisted of 19,260 women and 23,893 men with a mean age of 77 years. 11,245 (58.4%) women and 16,754 (70.1%) men died after cohort entry. Male sex was associated with a significantly increased risk of death (adjusted HR 1.45, 95% CI 1.42 to 1.49) and with a significantly increased risk of rehospitalisation for obstructive airways disease (adjusted HR 1.12, 95% CI 1.09 to 1.15).
CONCLUSION: Mean survival and time to rehospitalisation for obstructive airways disease are significantly better for female patients.

Entities:  

Mesh:

Year:  2010        PMID: 21113016     DOI: 10.1136/thx.2010.141978

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

1.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Brett C Bade; Eric C DeRycke; Christine Ramsey; Melissa Skanderson; Kristina Crothers; Sally Haskell; Bevanne Bean-Mayberry; Cynthia Brandt; Lori A Bastian; Kathleen M Akgün
Journal:  Ann Am Thorac Soc       Date:  2019-06

3.  Disparities in Hospitalized Chronic Obstructive Pulmonary Disease Exacerbations Between American Indians and Non-Hispanic Whites.

Authors:  Huimin Wu; Dorothy A Rhoades; Sixia Chen; Matt Slief; Carla A Guy; Adam Warren; Brent Brown
Journal:  Chronic Obstr Pulm Dis       Date:  2022-04-29

4.  Population-based burden of COPD-related visits in the ED: return ED visits, hospital admissions, and comorbidity risks.

Authors:  Karin B Yeatts; Steven J Lippmann; Anna E Waller; Kristen Hassmiller Lich; Debbie Travers; Morris Weinberger; James F Donohue
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

5.  Association of gender with outcomes in critically ill patients.

Authors:  Kamran Mahmood; Kamal Eldeirawi; Momen M Wahidi
Journal:  Crit Care       Date:  2012-05-22       Impact factor: 9.097

6.  Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality.

Authors:  Samy Suissa; Sophie Dell'Aniello; Pierre Ernst
Journal:  Thorax       Date:  2012-06-08       Impact factor: 9.139

7.  Two-year mortality of patients with COPD in primary health care: an observational study.

Authors:  Markos Minas; Ioanna Verrou-Katsarou; Parthena Mystridou; Eleni Apostolidou; Chrisi Hatzoglou; Konstantinos I Gourgoulianis
Journal:  Int J Gen Med       Date:  2012-10-05

8.  Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial.

Authors:  C E Bucknall; G Miller; S M Lloyd; J Cleland; S McCluskey; M Cotton; R D Stevenson; P Cotton; A McConnachie
Journal:  BMJ       Date:  2012-03-06

Review 9.  Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review.

Authors:  Tam Dang-Tan; Afisi Ismaila; Shiyuan Zhang; Victoria Zarotsky; Mark Bernauer
Journal:  BMC Res Notes       Date:  2015-09-21

10.  The risk of cancer in patients with generalized anxiety disorder: a nationwide population-based study.

Authors:  Cheng-Che Shen; Yu-Wen Hu; Li-Yu Hu; Man-Hsin Hung; Tung-Ping Su; Min-Wei Huang; Chia-Fen Tsai; Shuo-Ming Ou; Sang-Hue Yen; Cheng-Hwai Tzeng; Tzeon-Jye Chiou; Tzeng-Ji Chen; Chia-Jen Liu
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.